These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3259438)

  • 1. Response suppression in rats after bilateral microinjection of 5-hydroxytryptophan in lateral hypothalamus.
    Hingtgen JN; Shekhar A; DiMicco JA; Aprison MH
    Biol Psychiatry; 1988 Apr; 23(7):711-8. PubMed ID: 3259438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effect of 5-hydroxytryptophan on approach and avoidance behavior in rats.
    Park WK; Hingtgen JN; Aprison MH
    Pharmacol Biochem Behav; 1991 Jan; 38(1):191-4. PubMed ID: 2017445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Operant response suppression induced with systemic administration of 5-hydroxytryptophan is centrally mediated.
    Engleman EA; Murphy JM; Zhou FC; Aprison MH; Hingtgen JN
    Pharmacol Biochem Behav; 1995 Nov; 52(3):525-9. PubMed ID: 8545469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additional evidence that L-5-hydroxytryptophan discrimination models a unique serotonin receptor.
    Friedman R; Barrett RJ; Sanders-Bush E
    Psychopharmacology (Berl); 1983; 80(3):209-13. PubMed ID: 6137018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminative stimulus properties of L-5-hydroxytryptophan: behavioral evidence for multiple serotonin receptors.
    Barrett RJ; Blackshear MA; Sanders-Bush E
    Psychopharmacology (Berl); 1982; 76(1):29-35. PubMed ID: 6805004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of a 5-hydroxytryptophan-induced animal model of depression with a potent and selective 5-HT2 receptor antagonist (LY53857).
    Hingtgen JN; Fuller RW; Mason NR; Aprison MH
    Biol Psychiatry; 1985 Jun; 20(6):592-7. PubMed ID: 3873259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Action of chronically administered antidepressants on the serotonergic postsynapse in a model of depression.
    Nagayama H; Akiyoshi J; Tobo M
    Pharmacol Biochem Behav; 1986 Oct; 25(4):805-11. PubMed ID: 3491369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increases in avoidance responding produced by REM sleep deprivation or serotonin depletion are reversed by administration of 5-hydroxytryptophan.
    Smith RL; Kennedy CH
    Behav Brain Res; 2003 Mar; 140(1-2):81-6. PubMed ID: 12644281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral and prolactin responses to 5-hydroxytryptophan in rats treated during development with 5,7-dihydroxytryptamine.
    Breese GR; Vogel RA; Kuhn CM; Mailman RB; Mueller RA; Schanberg SM
    Brain Res; 1978 Oct; 155(2):263-75. PubMed ID: 308387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of chronic treatment with 5-hydroxytryptophan on cortical serotonin receptors in the rat.
    Pranzatelli MR
    Clin Neuropharmacol; 1988 Jun; 11(3):257-62. PubMed ID: 3261199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonergic and cholinergic mechanisms during disruption of approach and avoidance behavior.
    Aprison MH; Hingtgen JN; McBride WJ
    Fed Proc; 1975 Aug; 34(9):1813-22. PubMed ID: 1080120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiated 5-hydroxytryptophan induced response suppression in rats following chronic reserpine.
    Brugge KL; Hingtgen JN; Aprison MH
    Pharmacol Biochem Behav; 1987 Feb; 26(2):287-91. PubMed ID: 3495008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that taste aversion learning induced by l-5-hydroxytryptophan is mediated peripherally.
    Ervin GN; Carter RB; Webster EL; Moore SI; Cooper BR
    Pharmacol Biochem Behav; 1984 May; 20(5):799-802. PubMed ID: 6610880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postsynaptic serotonergic blockade following chronic antidepressive treatment with trazodone in an animal model of depression.
    Hingtgen JN; Hendrie HC; Aprison MH
    Pharmacol Biochem Behav; 1984 Mar; 20(3):425-8. PubMed ID: 6608737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of hypothalamic surgery on prolactin release induced by 5-hydroxytryptophan (5-HTP) in rats.
    Ohgo S; Kato Y; Chihara K; Imura H; Maeda K
    Endocrinol Jpn; 1976 Dec; 23(6):485-91. PubMed ID: 1088127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postsynaptic action by four antidepressive drugs in an animal model of depression.
    Nagayama H; Hingtgen JN; Aprison MH
    Pharmacol Biochem Behav; 1981 Jul; 15(1):125-30. PubMed ID: 6974869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mediation of ACTH and prolactin responses to 5-HTP by 5-HT2 receptors.
    Gartside SE; Cowen PJ
    Eur J Pharmacol; 1990 Apr; 179(1-2):103-9. PubMed ID: 2163847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the discriminative stimulus properties of l-5-hydroxytryptophan in the presence of either citalopram or Ro 4-4602.
    Winter JC; Rabin RA
    Pharmacol Biochem Behav; 1988 Jul; 30(3):613-6. PubMed ID: 3264918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-5-HTP facilitates the electrically stimulated flexor reflex in pithed rats: evidence for 5-HT2-receptor mediation.
    Skarsfeldt T; Arnt J; Hyttel J
    Eur J Pharmacol; 1990 Feb; 176(2):135-42. PubMed ID: 1968846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonergic reduction of dorsal central gray area stimulation-produced aversion.
    Kiser RS; German DC; Lebovitz RM
    Pharmacol Biochem Behav; 1978 Jul; 9(1):27-31. PubMed ID: 309135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.